dr. rogers discusses obinutuzumab, ibrutinib, and venetoclax combination in cll
Published 6 years ago • 637 plays • Length 1:25Download video MP4
Download video MP3
Similar videos
-
1:17
dr. rogers on benefits of ibrutinib combination in cll
-
2:42
dr. rogers discusses early intervention with ibrutinib in cll
-
1:02
dr. gerson on venetoclax/obinutuzumab combination in cll
-
1:05
dr. smith on using venetoclax versus ibrutinib in cll
-
9:15
obinutuzumab venetoclax for frontline cll
-
1:19
dr. rogers discusses data for ibrutinib in hairy cell leukemia
-
8:16
venetoclax and obinutuzumab in cll
-
1:16
dr. wierda on ibrutinib plus venetoclax in cll
-
0:51
dr. seymour on role of ibrutinib in cll
-
1:35
cll: venetoclax in combination with obinutuzumab
-
1:09
majic: venetoclax with acalabrutinib or obinutuzumab in cll
-
1:01
dr. abedin on the role of venetoclax plus obinutuzumab in cll
-
0:43
ideal patient for venetoclax/obinutuzumab combination | dr. jeff sharman | oncology brothers #2023
-
6:34
3-year follow-up of obinutuzumab, ibrutinib and venetoclax for cll
-
2:43
four-year follow-up from a phase ii study of obinutuzumab, ibrutinib, and venetoclax in cll
-
3:01
ibrutinib venetoclax for cll
-
12:05
venetoclax combinations, safety and efficacy
-
6:04
obinutuzumab, ibrutinib, and venetoclax for cll (chronic lymphocytic leukemia) treatment - asco 2022
-
4:07
management of cll progression after ibrutinib